Luigi Bartalena, MD - oneGRAVESvoice

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Researchers

Luigi Bartalena, MD

Post-Graduate School of Endocrinology
and Metabolism
University of Insubria
Via Ravasi 2
Varese, Italy

Luigi Bartalena is Professor of Endocrinology and Director of Post-Graduate School of Endocrinology and Metabolism at University of Insubria, Varese, Italy. He is also Head of endocrine unit at Ospedale di Circolo, Varese, Italy.

Dr. Luigi Bartalena received his medical degree (magna cum laude) from University of Pisa Medical School and postgraduate degree in endocrinology (magna cum laude) from University of Pisa Postgraduate School of Endocrinology. He has received a specialty certification in endocrinology from University of Pisa in 1978.

Luigi Bartalena has been a visiting fellow, visiting associate, and guest worker of Clinical Endocrinology Branch (CEB), at National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases (NIADDK), National Institutes of Health (NIH), Bethesda, USA. He has also been a visiting scientist of Genetics and Biochemistry Branch at NIDDK, NIH, Bethesda, USA.

Luigi Bartalena has been a member of European Group on Graves’ orbitopathy (EUGOGO), ordinary member of European Society of Endocrinology, secretary-elect of the European Thyroid Association, secretary of the European Thyroid Association, member of Associazione Medici Endocrinologi (AME), and member of the Committee for Clinical Affairs of the American Thyroid Association. He has received multiple awards like Schering Prize of the Italian Society of Endocrinology, Aldo Pinchera Lecture Prize of the European Thyroid Association, and Plenary Lecture, 15th International Thyroid Congress etc.


Representative Publications:

What to do for Moderate-to-Severe and Active Graves’ Orbitopathy If Glucocorticoids Fail?

CT of the Orbit in Graves’ Ophthalmopathy

Studies on the Occurrence of Ophthalmopathy in Graves’ Disease

Therapy of Graves’ Disease With Sodium Ipodate is Associated With a High Recurrence Rate of Hyperthyroidism

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.